About
Dr Kristian Steen Frederiksen is a senior consultant neurologist at the Danish Dementia Research Centre in Copenhagen, where he also serves as director of the Clinical Trial Unit. Dr Frederiksen is a clinician and researchers, and his areas of research cover biomarkers for the early detection of neurodegenerative dementias, clinical application of biomarkers, research in communication of diagnosis, early disease mechanisms and interventions. Dr Frederiksen is the principal investigator on a number of phase II and III trials in early Alzheimers disease.
Dr Frederiksen has received research grants and funding from the Innovation Foundation (through EU grant applications), AP Møller foundation and Rigshospitalets Research foundation. Dr Frederiksen serves on an advisory board for Novo Nordisk and has given lectures for Lundbeck Pharma, Novo Nordisk and Roche Denmark for which he has received no personal renumeration.